Boston Scientific (BSX) PT Raised to $37 at Citi
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $48.17 -3.39%
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Rating Summary:
33 Buy, 9 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 20 | New: 18
Join SI Premium – FREE
Citi raised its price target on Boston Scientific (NYSE: BSX) to $37.00 (from $34.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Reiterates Buy Rating on Boston Scientific (BSX), 'would not view a cybersecurity-related guidance change as reflecting negatively'
- Intuit (INTU) PT Raised to $290 at Piper Sandler
- Semtech Corp. (SMTC) PT Raised to $230 at UBS Following Strong Earnings, Guidance
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
